Table 23:
Quality of Life After Mechanical Thrombectomy Use in Acute and Subacute DVT in Randomized Controlled Trials
Results | ||||
---|---|---|---|---|
Author, year | Outcome measurement | MT | Comparator | P value |
PMT (AngioJet) | ||||
ATTRACT trial92 PMT vs. control (no procedure, anticoagulation alone) |
VEINES-QOL at 24 mo | 30.53 (SE ± 3.11) | 26.17 (SE ± 2.17) | P = .21 |
Vacuum Aspiration (Indigo) | ||||
No randomized studies met the inclusion criteria for this MT device | ||||
Rotational (Rotarex or Cleaner) | ||||
No randomized controlled trials met the inclusion criteria for this MT device | ||||
Ultrasound Assisted (EKOS) | ||||
Engelberger et al, 20152 | Chronic VEINES-QoL | 28.0 (SD ± 11.6) | 26.2 (SD ± 7.5) | P = .55 |
CAVA trial Notton et al, 20203,102 |
VEINES-QoL at 12 mo | 50.0 (SD ± 11.1) | 50.2 (SD ± 8.8) | P = .92 |
Abbreviations: ATTRACT, Acute venous Thrombosis: Thrombus Removal with Adjunctive Catheter-directed Thrombolysis; DVT, deep vein thrombosis; MT, mechanical thrombectomy; PMT, pharmacomechanical thrombectomy; SD, standard deviation; SE, standard error;
VEINES-QoL, Venous Insufficiency Epidemiologic and Economic Quality of Life Survey score.